Articles published by Clearmind Medicine Inc.
![](https://ml.globenewswire.com/media/52c0fa73-1317-4a42-bfa5-ea0252669a70/small/clearmindnewlogo-png.png)
![](https://ml.globenewswire.com/media/52c0fa73-1317-4a42-bfa5-ea0252669a70/small/clearmindnewlogo-png.png)
Via GlobeNewswire
Tickers
CMND
![](https://ml.globenewswire.com/media/52c0fa73-1317-4a42-bfa5-ea0252669a70/small/clearmindnewlogo-png.png)
![](https://ml.globenewswire.com/media/94cfe932-610a-4cd2-98a5-9e0699313ea1/small/clearmindlogo-png.png)
Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug
August 06, 2024
Via GlobeNewswire
Tickers
CMND
![](https://ml.globenewswire.com/media/94cfe932-610a-4cd2-98a5-9e0699313ea1/small/clearmindlogo-png.png)
![](https://ml.globenewswire.com/media/94cfe932-610a-4cd2-98a5-9e0699313ea1/small/clearmindlogo-png.png)
![](https://ml.globenewswire.com/media/94cfe932-610a-4cd2-98a5-9e0699313ea1/small/clearmindlogo-png.png)
![](https://ml.globenewswire.com/media/94cfe932-610a-4cd2-98a5-9e0699313ea1/small/clearmindlogo-png.png)
![](https://ml.globenewswire.com/media/94cfe932-610a-4cd2-98a5-9e0699313ea1/small/clearmindlogo-png.png)
![](https://ml.globenewswire.com/media/a7ea5023-f815-411c-bec6-7f78ceb35e2a/small/clearmind-png.png)
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment
June 28, 2024
Via GlobeNewswire
Tickers
CMND
![](https://ml.globenewswire.com/media/a7ea5023-f815-411c-bec6-7f78ceb35e2a/small/clearmind-png.png)
![](https://ml.globenewswire.com/media/19773564-50ba-496f-82c9-af36cfa887b7/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/19773564-50ba-496f-82c9-af36cfa887b7/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/19773564-50ba-496f-82c9-af36cfa887b7/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/19773564-50ba-496f-82c9-af36cfa887b7/small/logo-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Clearmind Medicine CEO Issues Letter to Shareholders
April 09, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Clearmind Medicine Completed Type A Meeting with the FDA
January 10, 2024
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.